MarginsXMarginsX
Home › Markets › SXTC

China SXT Pharmaceuticals Inc. (SXTC)

SXTC trades on Nasdaq. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$2.99
-0.33% on the day
Market cap
$310K
Nano cap
Revenue · 2025
$1.1M
-34.6% on 2024
Net income · 2025
-$6.2M
-545.2% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2026-03-31, https://www.sec.gov/Archives/edgar/data/1723980/000121390026074310/0001213900-26-074310-index.htm. Net income: SEC 20-F (us-gaap:NetIncomeLoss), fiscal year ended 2026-03-31.

Profile

FieldValue
TickerSXTC on Nasdaq
SectorThe Nasdaq screener gives no sector
IndustryThe Nasdaq screener gives no industry
CountryChina
IPO year2019
SEC CIK0001723980

Financials · 2025

LineValue
Revenue$1.1M
Net income-$6.2M
Operating income-$7.1M
Net margin-545.2%
Operating margin-625.9%
Revenue growth-34.6%
Cash$28.2M
Total assets$34.8M
P/E (computed)Net income was not positive
P/S (computed)0.3×

Warning signs

Cash runway
84.2 months
$28.2M cash at March 31, 2026
Share count, 1 year
See the dilution note
+31321.6% over 3 years
Going-concern doubt
Yes
20-F filed July 1, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors raise substantial doubt about the Company's ability to continue as a going concern."
20-F 2026-07-01
Cash and burn$28.2M cash; operating cash flow -$1.0M a quarter.Report 2026-03-31
Shares outstandingNo cover-page share count in XBRLCover page 2026-03-31
Reverse splits, 3 years3; latest 1-for-100 on 2026-10-26Source 2026-10-26
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 5 424B5 takedowns, 1 at the marketLatest 2026-06-01
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorENROME LLP, Singapore, SingaporePCAOB Form AP 2026-07-02
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2026
2026-03-31
$1.1M-$6.2M-$4.0M$28.2M$1000K$1.1M20-F 2026-07-01
FY 2025
2025-03-31
$1.7M-$3.3M-$2.3M$18.1M$1.5M$1.7M20-F 2026-07-01
FY 2024
2024-03-31
$1.9M-$3.1M-$1.9M$12.1M$1.1M$1.9M20-F 2024-08-13
FY 2023
2023-03-31
$2.0M-$5.9M-$81K$17.4M$293K$2.0M20-F 2024-08-13
FY 2022
2022-03-31
$2.6M-$5.7M$268K$15.6M$23K$2.6M20-F 2024-08-13
FY 2021
2021-03-31
$4.8M-$2.7M-$1.3M$13.4M$43K$4.8M20-F 2023-07-31
FY 2020
2020-03-31
$5.2M-$10.3M$934K$7.3M$80K$5.2M20-F/A 2023-05-19
FY 2019
2019-03-31
$7.0M$1.5M$239K$9.3M$70K$7.0M20-F 2021-08-13

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

The SEC filing list did not load in time for this page. It is on SEC EDGAR and in the full dossier.

Price moves

WindowReturn
1 week+6.0%
1 month-61.0%
3 months-99.1%
Year to date-100.0%
1 year-100.0%
From 52-week high-100.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers

No industry from the screener, so peers can't be matched.

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier